$0.4099
+0.02
(+5.1%)▲
Insights on Streamline Health Solutions Inc
Revenue is down for the last 2 quarters, 6.13M → 5.36M (in $), with an average decrease of 12.6% per quarter
Netprofit is up for the last 2 quarters, -11.91M → -1.37M (in $), with an average increase of 769.4% per quarter
In the last 1 year, Healthequity Inc has given 37.1% return, outperforming this stock by 110.1%
In the last 3 years, Healthequity Inc has given 0.1% return, outperforming this stock by 78.9%
4.88%
Downside
Day's Volatility :4.88%
Upside
0.0%
48.05%
Downside
52 Weeks Volatility :86.85%
Upside
74.69%
Period | Streamline Health Solutions Inc | Index (Russel 2000) |
---|---|---|
3 Months | -16.35% | 0.0% |
6 Months | 43.82% | 0.0% |
1 Year | -73.03% | 0.0% |
3 Years | -78.76% | -22.6% |
Market Capitalization | 24.2M |
Book Value | $0.75 |
Earnings Per Share (EPS) | -0.33 |
PEG Ratio | -0.44 |
Wall Street Target Price | 1.5 |
Profit Margin | -82.75% |
Operating Margin TTM | -71.44% |
Return On Assets TTM | -10.74% |
Return On Equity TTM | -68.83% |
Revenue TTM | 22.6M |
Revenue Per Share TTM | 0.4 |
Quarterly Revenue Growth YOY | -0.7000000000000001% |
Gross Profit TTM | 11.5M |
EBITDA | -7.7M |
Diluted Eps TTM | -0.33 |
Quarterly Earnings Growth YOY | 12.13 |
EPS Estimate Current Year | -0.34 |
EPS Estimate Next Year | -0.11 |
EPS Estimate Current Quarter | -0.04 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 265.94%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 22.4M | ↓ 8.11% |
Net Income | -5.9M | ↑ 89.24% |
Net Profit Margin | -26.22% | ↓ 13.49% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 20.7M | ↓ 7.25% |
Net Income | -2.9M | ↓ 51.18% |
Net Profit Margin | -13.8% | ↑ 12.42% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 11.3M | ↓ 45.3% |
Net Income | -4.8M | ↑ 67.62% |
Net Profit Margin | -42.3% | ↓ 28.5% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 17.4M | ↑ 53.17% |
Net Income | -6.9M | ↑ 44.13% |
Net Profit Margin | -39.8% | ↑ 2.5% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 24.9M | ↑ 43.21% |
Net Income | -11.4M | ↑ 64.51% |
Net Profit Margin | -45.72% | ↓ 5.92% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 22.6M | ↓ 9.21% |
Net Income | -18.7M | ↑ 64.31% |
Net Profit Margin | -82.74% | ↓ 37.02% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 6.2M | ↑ 3.76% |
Net Income | -3.1M | ↓ 4.1% |
Net Profit Margin | -50.47% | ↑ 4.14% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 6.7M | ↑ 8.49% |
Net Income | -2.2M | ↓ 30.47% |
Net Profit Margin | -32.35% | ↑ 18.12% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 5.3M | ↓ 20.95% |
Net Income | -2.9M | ↑ 32.95% |
Net Profit Margin | -54.41% | ↓ 22.06% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 5.8M | ↑ 8.21% |
Net Income | -2.5M | ↓ 13.31% |
Net Profit Margin | -43.59% | ↑ 10.82% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 6.1M | ↑ 6.29% |
Net Income | -11.9M | ↑ 373.6% |
Net Profit Margin | -194.21% | ↓ 150.62% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 5.4M | ↓ 12.59% |
Net Income | -1.4M | ↓ 88.5% |
Net Profit Margin | -25.55% | ↑ 168.66% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 31.7M | ↓ 14.52% |
Total Liabilities | 23.1M | ↑ 25.09% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 31.7M | ↓ 0.28% |
Total Liabilities | 15.6M | ↓ 32.13% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 26.0M | ↓ 17.93% |
Total Liabilities | 8.5M | ↓ 45.75% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 61.8M | ↑ 137.96% |
Total Liabilities | 27.8M | ↑ 227.18% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 61.5M | ↓ 0.48% |
Total Liabilities | 26.0M | ↓ 6.34% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 41.7M | ↓ 32.15% |
Total Liabilities | 22.9M | ↓ 11.86% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 62.2M | ↑ 9.23% |
Total Liabilities | 28.1M | ↓ 1.41% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 61.5M | ↓ 1.12% |
Total Liabilities | 26.0M | ↓ 7.28% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 56.5M | ↓ 8.18% |
Total Liabilities | 23.4M | ↓ 9.94% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 53.3M | ↓ 5.61% |
Total Liabilities | 22.2M | ↓ 5.18% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 41.1M | ↓ 22.9% |
Total Liabilities | 21.4M | ↓ 3.86% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 41.7M | ↑ 1.54% |
Total Liabilities | 22.9M | ↑ 7.36% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.4M | ↓ 31.22% |
Investing Cash Flow | -3.0M | ↑ 61.01% |
Financing Cash Flow | -638.0K | ↓ 46.85% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.0K | ↓ 100.57% |
Investing Cash Flow | -3.4M | ↑ 13.55% |
Financing Cash Flow | 2.7M | ↓ 521.79% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -5.8M | ↑ 71862.5% |
Investing Cash Flow | 9.5M | ↓ 377.42% |
Financing Cash Flow | -2.9M | ↓ 209.36% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -3.5M | ↓ 39.13% |
Investing Cash Flow | -13.2M | ↓ 239.21% |
Financing Cash Flow | 24.1M | ↓ 920.56% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -7.1M | ↑ 103.85% |
Investing Cash Flow | -1.9M | ↓ 85.31% |
Financing Cash Flow | 5.8M | ↓ 76.02% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.8M | ↑ 5.29% |
Investing Cash Flow | -564.0K | ↑ 55.8% |
Financing Cash Flow | 8.1M | ↑ 135150.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.4M | ↑ 36.84% |
Investing Cash Flow | -490.0K | ↓ 13.12% |
Financing Cash Flow | -2.2M | ↓ 126.97% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 126.0K | ↓ 105.2% |
Investing Cash Flow | -433.0K | ↓ 11.63% |
Financing Cash Flow | -304.0K | ↓ 86.11% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.1M | ↓ 942.86% |
Investing Cash Flow | -640.0K | ↑ 47.81% |
Financing Cash Flow | -198.0K | ↓ 34.87% |
Sell
Neutral
Buy
Streamline Health Solutions Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Streamline Health Solutions Inc | 24.21% | 43.82% | -73.03% | -78.76% | -71.34% |
Solventum Corp | -11.81% | -17.44% | -17.44% | -17.44% | -17.44% |
Veeva Systems Inc. | -15.62% | -4.25% | -11.39% | -40.54% | 10.17% |
Ge Healthcare Technologies Inc. | -3.32% | 11.22% | -4.15% | 27.54% | 27.54% |
Healthequity Inc | 2.46% | 17.61% | 38.04% | 0.15% | 23.92% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Streamline Health Solutions Inc | NA | NA | -0.44 | -0.34 | -0.69 | -0.11 | NA | 0.75 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Veeva Systems Inc. | 51.25 | 51.25 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 22.68 | 22.68 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
Healthequity Inc | 127.63 | 127.63 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Streamline Health Solutions Inc | Buy | $24.2M | -71.34% | NA | -82.75% |
Solventum Corp | Hold | $10.8B | -17.44% | NA | 15.73% |
Veeva Systems Inc. | Buy | $28.2B | 10.17% | 51.25 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $35.6B | 27.54% | 22.68 | 8.05% |
Healthequity Inc | Buy | $7.1B | 23.92% | 127.63 | 5.57% |
Tamarack Advisers, LP
Harbert Fund Advisors Inc
Perkins Capital Management Inc
Vanguard Group Inc
Herald Investment Management Ltd
Nicholas Hoffman & Company, LLC
streamline health solutions, inc. supports revenue cycle optimization for healthcare enterprises. our integrated solutions, technology-enabled services and analytics enable providers to drive reimbursement in a value-based world. we share a common calling and commitment to advance the quality of life and the quality of healthcare — for society, our industry, our clients and the communities they serve, and the individual patient. all of our solutions are designed with an enterprise vision in mind. by implementing our solutions, healthcare organizations can improve the flow and management of critical patient information. each of our solutions helps transform and structure data between disparate systems into actionable information, giving you comprehensive access to clinical, financial, and administrative intelligence. our solution suites include: him, coding & cdi • clinical documentation improvement (cdi) • code auditing services & technology • enterprise content management • release of
Organization | Streamline Health Solutions Inc |
Employees | 77 |
CEO | Mr. Wyche T. Green III |
Industry | Technology Services |
A Spac I Acquisition Corp
$0.41
+5.1%
Keyarch Acquisition Corp
$0.41
+5.1%
Connexa Sports Technologies Inc
$0.41
+5.1%
Us Value Etf
$0.41
+5.1%
First Wave Biopharma Inc
$0.41
+5.1%
Global X Msci Next Emerging
$0.41
+5.1%
Fat Projects Acquisition Corp
$0.41
+5.1%
Goal Acquisitions Corp
$0.41
+5.1%
Capital Link Global Fintech
$0.41
+5.1%